Skip to main content
. 2018 Apr 18;8(27):14838–14847. doi: 10.1039/c8ra01749b

Fig. 7. Significant changes in metabolite biomarker candidates in control and model groups. (A) Heatmap visualisation for serum samples from the control and model groups. (B) Unsupervised PCA analysis of different groups. (C) VIP scores of the metabolite marker candidates.

Fig. 7